Combined effect of pyrazinamide and ofloxacin within the human macrophage (Q73087296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Combined effect of pyrazinamide and ofloxacin within the human macrophage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

1 reference

Sbarbaro JA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Iseman MD

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Crowle AJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

Tubercle and lung disease

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

491-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

The combined effect of rifampin and pyrazinamide within the human macrophage

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Mycobacteria and the new quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Drug treatment of tuberculosis--1992

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Chemoprophylaxis of Multidrug-Resistant Tuberculous Infection in HIV-Uninfected Individuals Using Ciprofloxacin and Pyrazinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990045-3

7 January 2021

10.1016/S0962-8479(96)90045-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9039440%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference